Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipocyte-Derived Leptolin Enhances Energy Expenditure and Prevents Obesity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Global trends, epidemiological patterns, and disability burden of metabolic dysfunction-associated steatotic liver disease-related cirrhosis from 1990 to 2021: A comprehensive analysis of the Global Burden of Disease study.

The Journal of international medical research·2026
Same author

A small-molecule stabilizer of the calpastatin-calpain-2 complex restores mitochondrial function and mitigates neurodegeneration.

Science advances·2026
Same author

Strategic modification of outer branched side chains in multi-modal phototheranostic nanoplatform for synergistic breast cancer therapy.

Journal of colloid and interface science·2026
Same author

Ephrin and Eph family proteins: Molecular mechanisms of signaling pathways and their role in neural injury repair.

Neural regeneration research·2026
Same author

Bacteria and phage consortia modulate cecal SCFA production and host metabolism to enhance feed efficiency in ducks.

Microbiome·2026

Related Experiment Video

Updated: Jun 28, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K

Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization.

Ran Zhang1,2, Lan Huang3, Xiaohan Zhang4

  • 1School of Basic Medicine Sciences, Anhui Medical University, Hefei, Anhui 230031, PR China.

Journal of Proteome Research
|April 11, 2024
PubMed
Summary

Researchers developed a high-throughput proteomics platform to screen nanobodies against SARS-CoV-2 variants. Two nanobodies, C-282 and C-39, showed broad neutralizing activity against multiple variants, offering potential future treatments.

Keywords:
SARS-CoV-2microarraynanobodyneutralizationproteomics

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.2K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

713

Related Experiment Videos

Last Updated: Jun 28, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.2K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

713

Area of Science:

  • Virology and Immunology
  • Biotechnology and Proteomics

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants exhibit immune evasion, necessitating novel therapeutic strategies.
  • Nanobodies offer advantages like small size, stability, and high affinity for developing neutralizing antibodies.

Purpose of the Study:

  • To establish an integrated proteomics platform for high-throughput screening of nanobodies against SARS-CoV-2 spike variants.
  • To identify and characterize nanobodies with broad neutralizing activity against diverse SARS-CoV-2 variants.

Main Methods:

  • Immunization of a camel with wild-type SARS-CoV-2 spike protein (S1 subunit) and construction of a nanobody phage library.
  • High-throughput screening of the nanobody library against 72 SARS-CoV-2 spike variants.
  • In vitro pseudovirus-based neutralization assays to validate nanobody efficacy.

Main Results:

  • Identification of two nanobodies, C-282 and C-39, demonstrating broad neutralizing activity.
  • These nanobodies effectively neutralized six non-Omicron variants (D614G, Alpha, Beta, Gamma, Delta, Kappa) and five Omicron variants (BA.1-5).

Conclusions:

  • The developed proteomics platform is effective for identifying nanobodies with broad neutralizing capabilities against SARS-CoV-2 variants.
  • Identified nanobodies hold potential for future therapeutic development against SARS-CoV-2 infections.